Showing results (191-200 of 236) with videos related to
Sort By:
Pageof 24
Pharmacogenetics|January 26, 1999
Determination of the enzymes responsible for activation of the heterocyclic amine 2-amino-3-methylimidazo[4,5-f]quinoline in the human breastJ A Williams, E M Stone, B C Millar, et al.Carcinogenesis|August 1, 1994
Reduced genotoxicity of [D5-ethyl]-tamoxifen implicates alpha-hydroxylation of the ethyl group as a major pathway of tamoxifen activation to a liver carcinogenD H Phillips, G A Potter, M N Horton, et al.Carcinogenesis|April 1, 1985
Evidence for N-(deoxyguanosin-8-yl)-1-aminopyrene as a major DNA adduct in female rats treated with 1-nitropyreneC A Stanton, F L Chow, D H Phillips, et al.IARC Scientific Publications|January 1, 1990
Linear relationship between DNA adducts in human lung and cigarette smokingR C Garner, J Cuzick, D Jenkins, et al.Biochemical Pharmacology|May 11, 1995
The role of the N-(hydroxymethyl)melamines as antitumour agents: mechanism of action studiesH M Coley, N Brooks, D H Phillips, et al.Carcinogenesis|May 1, 1999
Heterocyclic aromatic amines induce DNA strand breaks and cell transformationW Pfau, F L Martin, K J Cole, et al.Prostate Cancer and Prostatic Diseases|December 24, 2002
The influence of dietary and environmental factors on prostate cancer riskG G Kooiman, F L Martin, J A Williams, et al.Carcinogenesis|June 1, 1991
The metabolic activation of dibenz[a,h]anthracene in mouse skin examined by 32P-postlabelling: minor contribution of the 3,4-diol 1,2-oxides to DNA bindingS Lecoq, M N She, A Hewer, et al.Toxicology and Applied Pharmacology|July 2, 2005
DNA adducts: mass spectrometry methods and future prospectsP B Farmer, K Brown, E Tompkins, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 1, 1995
Carcinogen-DNA adducts in human breast tissueF P Perera, A Estabrook, A Hewer, et al.Pageof 24